Showing results (21-30 of 53) with videos related to
Sort By:
Pageof 6
Progress in Brain Research|August 11, 2010
Pathophysiological roles for purines: adenosine, caffeine and urateMicaela Morelli, Anna R Carta, Anil Kachroo, et al.Brain Research|April 25, 2003
EEG modifications in the cortex and striatum after dopaminergic priming in the 6-hydroxydopamine rat model of Parkinson's diseaseVasily V Vorobyov, Nikolai V Schibaev, Micaela Morelli, et al.Parkinsonism & Related Disorders|June 28, 2008
Direct and indirect striatal efferent pathways are differentially influenced by low and high dyskinetic drugs: behavioural and biochemical evidenceAnna R Carta, Lucia Frau, Silvia Pontis, et al.Journal of Neurochemistry|June 15, 2006
Potentiation of amphetamine-mediated responses in caffeine-sensitized rats involves modifications in A2A receptors and zif-268 mRNAs in striatal neuronsElisabetta Tronci, Nicola Simola, Anna R Carta, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|March 16, 2018
Neuroinflammation in L-DOPA-induced dyskinesia: beyond the immune functionAugusta Pisanu, Laura Boi, Giovanna Mulas, et al.Neurotoxicity Research|June 16, 2009
Progressive dopaminergic degeneration in the chronic MPTPp mouse model of Parkinson's diseaseNicoletta Schintu, Lucia Frau, Marcello Ibba, et al.The European Journal of Neuroscience|March 4, 2008
Long-term increase in GAD67 mRNA expression in the central amygdala of rats sensitized by drugs and stressAnna R Carta, Carmen Casal Moreno, Cristina Cadoni, et al.Experimental Neurology|February 11, 2004
Blockade of A2A receptors plus l-DOPA after nigrostriatal lesion results in GAD67 mRNA changes different from l-DOPA alone in the rat globus pallidus and substantia nigra reticulataAnna R Carta, Mojgan Aghazadeh Tabrizi, Pier G Baraldi, et al.The European Journal of Neuroscience|February 28, 2009
PPAR-gamma-mediated neuroprotection in a chronic mouse model of Parkinson's diseaseNicoletta Schintu, Lucia Frau, Marcello Ibba, et al.Neurobiology of Disease|August 20, 2014
Dynamic changes in pro- and anti-inflammatory cytokines in microglia after PPAR-γ agonist neuroprotective treatment in the MPTPp mouse model of progressive Parkinson's diseaseAugusta Pisanu, Daniela Lecca, Giovanna Mulas, et al.Pageof 6